Breast Clinical Trial Program

BWeL Study: Alliance 011401
A randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer.
ECOG 2112
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer.
Champions Oncology - Breast Initiative
Tumor Graft Tissue Banking Program.
E1Z11
A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ONLY ASIAN AND NATIVE HAWAIIAN/PACIFID ISLANDERS COHORTS OPEN.
NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosamide Followed By Weekly Paclitaxol with or without Carboplatin for Node-Positive or High Risk Node- Negative Triple Negative Invasive Breast Cancer Negative Axillary Nodes after Neoadjuvant Chemotherapy.
NSABP-51
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Axillary Nodes Before Neoadjuvant Chemotherapy who Convert to Pathologically Negative Axillary Nodes after Neoadjuvant Chemotherapy.

To access the full protocols, please contact: Rita McTighe, Oncology Clinical Research Coordinator, at Rita.Mctighe@rwjbh.org or call (732) 923-6564.